Institution

Ospedale Regina Margherita

Turin, ItalyWebsite

Also known as: Ospedale infantile Regina Margherita · Regina Margherita hospital · OIRM

5running trials
2closed trials
4,039publications (OpenAlex)

Running trials

Recruiting
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
NCT07088068· Phase 3· Sanofi· Source
Recruiting
Functional Capacity in Anderson-Fabry Disease Patients
NCT06884358· IRCCS Policlinico S. Donato· Source
Recruiting
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
NCT05748171· Phase 2· Pfizer· Source
Recruiting
Multicenter Italian Cohort Study on Tuberculosis in Pediatric Age
NCT06289660· Meyer Children's Hospital IRCCS· Source
Active, not recruiting
Safety/PK Study of Gene Modified Donor T Cell Infusion in Children With Recurrent Hem Malignancies After Allo Transplant
NCT03459170· Phase 1· Bellicum Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Acute lymphoblastic leukaemia1 recruiting
Childhood cancers1 recruiting
Tuberculosis1 recruiting
Type 1 diabetes1 recruiting

Closed trials

Terminated
A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
NCT04501614· Phase 1/2· Takeda· Source
Recruiting
Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
NCT03695978· Octapharma· Source

Registry name variants (9)

Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.

Ospedale Infantile Regina Margherita
Torino, 10126
1 trial
- NCT05748171A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
Ospedale Infantile Regina Margherita
Turin, 10126
1 trial
- NCT03459170Safety/PK Study of Gene Modified Donor T Cell Infusion in Children With Recurrent Hem Malignancies After Allo Transplant
Ospedale Infantile Regina Margherita - A.O.U. Città della Salute e della Scienza-Site Number: 3800010
Turin, Torino 10126
1 trial
- NCT07088068A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
  Contact: Davide Tinti
Ospedale Infantile Regina Margherita - INCIPIT - PIN
Turin, Piedmont 10126
1 trial
- NCT04501614A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Ospedale Regina Margherita
Torino, 10126
1 trial
- NCT06289660Multicenter Italian Cohort Study on Tuberculosis in Pediatric Age
  Contact: Silvia Garazzino
Ospedale Regina Margherita
Turin, 10126
1 trial
- NCT03695978Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
  Contact: Cristina Solomon, MD
Regina Margherita Hospital
Turin, Turin 10124
1 trial
- NCT06884358Functional Capacity in Anderson-Fabry Disease Patients
  Contact: Massimo Piepoli, MD, PhD
Ospedale Infantile Regina Margherita - Oncoematologie Pediatrica
Turin, 10126
Ospedale Infantile Regina Margherita (Site 1604)
Turin, Piedmont 10126

Institution data: ROR 04e857469 (CC0-1.0)Updated 7 Nov 2026

Report an error